The Pros And Cons Of Epipens

Superior Essays
According to the New York Times, the cost of EpiPens has risen from $57 in 2007 to over $600 for a pack of two in 2016. EpiPens are vital to the safety of those who have life-threatening allergies to things such as bees or peanuts and it is recommended that their EpiPens be replaced every year. People with a need for EpiPens must find a way to pay the $600 for them when they expire each year. The dramatic increase in price is due to the monopoly that EpiPen has over the industry of epinephrine. After a company creates a unique drug, it is issued a patent that prevents any other sellers from entering the industry, giving the single company the power to charge whatever price that they see fit. Patents give pharmaceutical companies monopolies …show more content…
These obscene prices have sparked a massive protest from people who rely on this medicinal product to survive. The increase in price has made it harder for many to afford so many have demanded a decrease in price. However, the company argues that since they made the product, they should be allowed to sell their product for whatever price they decide on.

Pros of Patenting (Megan): Medical drug prices are affected greatly by the existence of patents. Many economists support the phenomenon of patenting drugs due to the benefits that patents have in the field of medicine and the drawbacks that can exist when they are not used. For example, patents are crucial to the research and development of new drugs. For a company to get a drug to the market, they must go through a very challenging, time-consuming, and tedious process of attempting to discover and produce a new drug. This task includes numerous failures and even if a new drug is discovered, it is not always approved for distribution in the market. It often takes up to twenty years to complete
…show more content…
Economists from this school of thought believe that drug patenting is unfair to consumers as patenting creates a monopoly. Big corporations claim intellectual property of the products through a patent and are given the authority to produce this drug. “A drug company that holds patents on a medicine has the right to prevent others from manufacturing it “ (“The Impact of Patents on Access to Medicines”). Therefore, pharmaceutical companies have the legal right to sue other companies that attempt to produce similar drugs. Thus the company holding the patent becomes the sole producer of that patented drug. As a result, there are no other company that can produce the drug and consequently, no close substitutes of such a drug. Companies now have the authority to “charge an artificially high price”(“The Impact of Patents on Access to Medicines”). With no competition or restrictions, there is nothing holding back drug companies. If a consumer wants to purchase this patented drug, the consumer must buy the drug from that specific company at the set price. Furthermore, “patent protected drugs are often essential for people’s health or even their lives. Allowing a drug company to have a monopoly where it can charge whatever it can force the individual, or more typically the insurer or the government, to pay makes little sense” (Baker). Medical pharmaceuticals are perfectly inelastic, meaning that at any price,

Related Documents

  • Improved Essays

    These payments are attempts at resolving disputes over the legitimacy and/or infractions of the patents held by these brand-name drug manufacturers. Since competition from generic drug manufacturers moderates the prices of drugs, these “pay for delaying” or “reverse…

    • 1014 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Bayh-Dole Act 1970

    • 796 Words
    • 4 Pages

    48 However, the Bayh-Dole Act has resulted in direct institutional ownership of parts of the intellectual property that protects many new drugs.49 To justify granting these private patent rights for government-sponsored inventions, one cannot use the typical innovation incentive of patents, because academic researchers have been innovating long before the Bayh-Dole Act and are primarily motivated by a desire for prestige.so Instead, Bayh-Dole patents typically are justified under commercialization theory-the idea that companies need exclusive patent rights to bring an invention to market." ' Commercialization theory is not appropriate for many industries, but exclusive rights may be needed in the pharmaceutical industry because of the high cost of FDA approval and low cost of…

    • 796 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    According to a survey conducted by the Commonwealth Fund, 35 percent of Americans have difficulty paying their medical bills, and 25 percent do not visit a doctor when they're sick, due to the cost. (Mercola) C. Another problem with the US health care system is that as opposed to other countries, American laws prevents the government from controlling drug prices. (Mercola) 1. An example of this is the recent price increase of Daraprim that was priced at $750 by Turing Pharmaceuticals, simply because they could. (Pollack) 2.…

    • 674 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    Daraprim Case Study

    • 1229 Words
    • 5 Pages

    This was made apparent during questioning when overnight the 60 year old drug went from $13 per pill to the current $750 per pill. She states the cost is justified in order to do research and development for all of the disease that are…

    • 1229 Words
    • 5 Pages
    Improved Essays
  • Great Essays

    Consumers of pharmaceuticals are affected by a number of factors that can alter and dictated their cost. The EpiPen increased its price by about $500 from the year 2007 to 2016, without the price being influenced by shortages or inflation (Babcock). The change that occurred was not justified by advancements because the exact same components that were being sold in 2007, were in the 2016 product. This presents inconsistencies and speculation. What could cause the rising cost to consumers, if it was not innovation, inflation, or scarcity?…

    • 1475 Words
    • 6 Pages
    Great Essays
  • Superior Essays

    These changes to the American food and drug market grew alongside the new focus on patenting. Patenting allowed companies to innovate new ideas and products and secure their ability to sell them. Drug patenting became hugely competitive and lucrative; because of this, many drugs that would be useful to the American product were sold for fortunes, in an attempt to fund the trials for new drugs to then be patented again. There were concerns among the public but there was no system to take in their questions or concerns. The American public had become a victim of the capitalist…

    • 1537 Words
    • 7 Pages
    Superior Essays
  • Improved Essays

    The Wall Street Journal writer, Drew Altman, states that “seventy-six percent of the public blames drug companies for high drug prices – with just ten percent blaming insurers” (Altman). Since the main buyers of medications are private insurers and the federal government, the pricing decision commonly does not consider the patient’s affordability. Pharmaceutical firms such as Medicare are not allowed to discuss prices with manufacturers while the Food and Drug Administration (FDA) does not consider cost in medication approval at all. Rare value and lack of alternatives influence high costs and “although some price increases have been caused by shortages, others have resulted from a business strategy of buying old neglected drugs and turning them into high-priced ‘specialty drugs’” (Pollack).…

    • 727 Words
    • 3 Pages
    Improved Essays
  • Great Essays

    Epipen Case Study

    • 1781 Words
    • 8 Pages

    In turn, pharmaceutical prices have also increased, as seen with the price of the EpiPen. Furthermore, a study done by the Congressional Budget Office emphasizes the lack of the output of new drugs in recent years, which highlights the need for an increase in further research and development (“Research and Development,” 2006). This being said, society’s need for new, innovative pharmaceuticals is only possible through further research and development, which requires sufficient funding from pharmaceutical companies that is attained through drug…

    • 1781 Words
    • 8 Pages
    Great Essays
  • Improved Essays

    Other than competition, the articles state about having more bargaining power with the pharmaceutical companies. The United States health care system, allows insurers like Medicare to bargain to set enrollees’ drug prices could serve as something of a stand-in (Taylor, 2015). A way to pay for low-cost drugs, insurers can negotiate with the pharmaceutical on getting discounts where they can bring down the prices or they can even question the value of their drugs and compare to similar drugs. But in order to have more bargaining power, there need to be more drugs available to treat the particular conditions (Taylor, 2015). However, if the drug is really effective and it’s the only pharmaceutical that has the drug, they are unlikely to lower price and could even put a heavier cost.…

    • 1525 Words
    • 7 Pages
    Improved Essays
  • Improved Essays

    Disease Mongering Essay

    • 1290 Words
    • 6 Pages

    While critics fail to recognise the consumer-origin for the demand of treatment drugs, they do recognise the opportunistic nature of marketing and consumerism. Pharmaceutical companies take advantage of the human pursuit of perfection. As is human nature, we are creatures striving to improve our own desirability and longevity. Consumers create the market for drugs that eliminate or reduce illnesses and ailments viewed as undesirable. Pharmaceutical companies merely take advantage of that, introducing quick-fix ways by which health and wellness can be…

    • 1290 Words
    • 6 Pages
    Improved Essays
  • Decent Essays

    Inelastic products however are not the same, they do not keep customers because their prices are low, or because it is a well-known brand name. Pharmaceutical companies known that their market is dependent on their products and therefore they can raise their prices. These are a product without which the consumer would not be able to survive, that is why when there is a dramatic price increase there is not the same decrease in quantity demand. For example the price of cigarettes has recently risen but this has not encouraged many smokers to quit, this is because they are addicted and can't stop therefore they are willing to pay the higher price for their nicotine…

    • 116 Words
    • 1 Pages
    Decent Essays
  • Brilliant Essays

    This in turn makes the price of drugs go up, because when there are less new drugs being created there are only the companies that produced the drugs to begin…

    • 1170 Words
    • 5 Pages
    Brilliant Essays
  • Superior Essays

    Americans use more prescription drugs than any other developed country. Prescription drugs only represent 12 percent of total health care costs in the United States, but the rising prices of those drugs is an issue that keeps reoccurring not only for patients, but for prescribers, payers, and policy makers. There are people that believe that the rise in price of these drugs is appropriate, but if they keep on rising in price, the United States will start suffering not only financially but medically. Despite a lot of other aspects of the economy rising in price, pharmaceutical drugs should be lowered, or should at least be kept at a reasonable rate. The rise in prices of prescription drugs is an issue that does not seem to be going away…

    • 2472 Words
    • 10 Pages
    Superior Essays
  • Great Essays

    The Medicines Patent Pool

    • 1428 Words
    • 6 Pages

    According to Ellen ‘t Hoen, the founder of the Medicines Patent Pool (MPP), the “pool” is at the center of where profit and health collide. The basic premise of the patent pool is for the pharmaceutical companies to profit, while still helping to provide low cost generics to the world’s population. For instance, the price for HIV medication in 2002 ran an average of $12,000 per patient, per year. Western drug companies holding the patents to this medication were not necessarily willing to make them available. As a result of the intellectual property rules laid out by the World Trade Organization, all companies are required to provide patents for pharmaceuticals.…

    • 1428 Words
    • 6 Pages
    Great Essays
  • Improved Essays

    Ratio Of Patient Care

    • 1165 Words
    • 5 Pages

    This is mostly due to the high amount of FDA (Food and Drug Administration) restrictions and laws they have put in place. Only about 1% of drugs on trial actually make it to shelves. Some trials take about 5-20 years to complete and to pass the FDA steps and stages to ensuring it is a usable and sellable product that does not hurt the human population. Because of the time invested into the trials and how long it takes for the drug to actually be cleared, the amount of funding needed in order to keep the trials running is very extensive. Due to the time and amount of funds that are needed, pharmaceutical companies have a extremely high development cost for drugs.…

    • 1165 Words
    • 5 Pages
    Improved Essays